TG 02 in patients with solid tumours.

Trial Profile

TG 02 in patients with solid tumours.

Phase of Trial: Phase I

Latest Information Update: 29 Nov 2012

At a glance

  • Drugs TG 02 (Primary)
  • Indications Solid tumours
  • Focus Adverse reactions
  • Most Recent Events

    • 29 Nov 2012 Status changed from unconfirmed to planning.
    • 27 Nov 2012 no mention of solid tumour trials planned in latest MR, 9144046
    • 13 Sep 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top